Associated Papers
The likelihood approach for potential role of "GABRG2 (C588T, C315T) gene polymorphisms" on the poor response to carbamazepine therapy in Pakhtun population of Pakistan.
Ullah S et al.
Medicine, 2022
Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.
Guerin AA et al.
Neuroscience and Biobehavioral Reviews, 2021
Vitamin B6 and homocysteine levels in carbamazepine treated epilepsy of Khyber Pakhtunkhwa.
Shakir S et al.
African Health Sciences, 2017
Mutation Screening of the γ-Aminobutyric Acid Type-A Receptor Subunit γ2 Gene in Korean Patients with Childhood Absence Epilepsy.
Kim YO et al.
Journal of Clinical Neurology (seoul, Korea), 2012
Genetic factors modulating the response to stimulant drugs in humans.
Hart AB et al.
Current Topics in Behavioral Neurosciences, 2012
Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies.
Shi X et al.
Journal of Human Genetics, 2010
Screening of GABA(A)-receptor gene mutations in primary dystonia.
Shang H et al.
European Journal of Neurology, 2007
Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures.
Ito M et al.
Neuroscience Letters, 2005
Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder.
Nishiyama T et al.
The Pharmacogenomics Journal, 2005
Failure to find causal mutations in the GABA(A)-receptor gamma2 subunit (GABRG2) gene in Japanese febrile seizure patients.
Nakayama J et al.
Neuroscience Letters, 2003
Mutations in GABRG2 receptor gene are not a major factor in the pathogenesis of mesial temporal lobe epilepsy in Indian population.
Dixit AB et al.
Annals of Indian Academy of Neurology, 0
Select a paper to view details